|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-05-06 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 14-05-06 | Actavis : M&A frenzy in healthcare sector | RE |
Company details: Forest Laboratories, Inc.
Forest Laboratories, Inc.
909 Third Avenue
10022-4731, New York
+212-421-7850
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +5.13% | +58.93% | +120.37% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +70.28% | 625B | |
| -1.48% | +0.47% | +23.08% | +96.78% | 511B | |
| +0.54% | +8.95% | +39.45% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.02% | 366B | |
| +0.30% | +6.35% | +21.84% | +49.62% | 291B | |
| -0.03% | +6.04% | +0.40% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +60.53% | 237B | |
| -1.88% | +0.02% | +23.77% | +98.00% | 194B | |
| Average | -0.56% | +6.31% | +35.38% | +69.51% | 445.32B | |
| Weighted average by Cap. | -0.57% | +6.91% | +40.78% | +81.10% |
- Stock Market
- Stocks
- Stock
- Company Forest Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
